Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nizaracianine Triflutate for Ureter Visualization (TRIPHASE)
NCT06101745Phase 3Recruiting
- Sponsor
- Curadel Surgical Innovations, Inc.
- Start
- Jun 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of nizaracianine triflutate in ureteral injury, sponsored by Curadel Surgical Innovations, Inc.. Started Jun 2024; status: recruiting.
02
Drugs
nizaracianine triflutate
03
Conditions
ureteral injury
Beyond the preview
Go deeper on NCT06101745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101745.